Thu, December 15, 2022
Wed, December 14, 2022
Tue, December 13, 2022
Mon, December 12, 2022
Fri, December 9, 2022
Thu, December 8, 2022

Christopher Raymond Maintained (AMGN) at Buy with Increased Target to $299 on, Dec 13th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-299-on-dec-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $297 to $299 on, Dec 13th, 2022.

Christopher has made no other calls on AMGN in the last 4 months.



There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
  • Carter Gould of "Barclays" Downgraded from Hold to Sell and Held Target at $234 on, Monday, October 31st, 2022

Publication Contributing Sources